Mumbai, July 16 -- Lupintoday announced the launch of Loteprednol Etabonate Ophthalmic Suspension, 0.5%, in the United States. Loteprednol Etabonate Ophthalmic Suspension, 0.5% is bioequivalent to Lotemax(R) Ophthalmic Suspension, 0.5%, of Bausch & Lomb Inc.

Published by HT Digital Content Services with permission from Capital Market....